Alembic Pharmaceuticals informs about press release

04 May 2021

Alembic Pharmaceuticals has informed that the Company's joint venture, Aleor Dermaceuticals, has received US Food and Drug Administration (USFDA) Tentative Approval for Metronidazole Gel USP, 1%. In this regard, the company has enclosed a press release on 4th May 2021 titled ‘Alembic Pharmaceuticals announces its joint venture Aleor Dermaceuticals receives USFDA Tentative Approval for Metronidazole Gel USP, 1%’.

The above information is a part of company’s filings submitted to BSE.

Related Alembic Pharmaceuticals Ltd. Links:

Alembic Pharma Share Price

1003.00 -3.80 (-0.38%) May 05, 09:23
1 Year Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 645.00
Dr. Reddys Lab 5109.00
Lupin 1057.25
Piramal Enterprises 1680.00
Cadila Healthcare 570.00
View more..
Sensex vs Alembic Pharma